Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer
We brought in the Germans to expand enrollment for 108 in Breast Cancer. Dr Bucholz of Hamburg and Dr Emons (he worked on the Phase II study for Endometerial Cancer)of Frauenklinik. Things are finally heating up for Aezs. We might even get a NDA for Aezs 130 if we are lucky.